#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bronchiectasis Pseudoxanthoma elasticum B-cell small lymphocytic lymphoma refractory Hyperinsulinism Squamous cell carcinoma of head and neck Acute leukaemia Brain stem glioma Pemphigoid Chronic hepatitis B Alagille syndrome Thalassaemia alpha Congenital growth hormone deficiency Metastatic malignant melanoma Antiphospholipid antibodies Cutaneous T-cell lymphoma stage II More trials…

    Learn about Rare Diseases

    Prolymphocytic leukaemia – Basic Information Inclusion body myositis – Treatment Uterine leiomyosarcoma – Basic Information Immunodeficiency congenital – Life with Disease Atypical haemolytic uraemic syndrome – Diagnostics Glycogen storage disease type V – Diagnostics Mast cell activation syndrome – Life with Disease Epidermolysis bullosa – Trials in Disease Undifferentiated sarcoma – Diagnostics Mucopolysaccharidosis I – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abiraterone Acetate LY3537031 Daplusiran Ticagrelor Pehero Ipn01194 Capsaicin Calcium Chloride Dihydrate Cevostamab Mk-0482 Toripalimab DCC-3084 Methadone Hydrochloride ARGININE GLUTAMATE Sotatercept Remdesivir Atacicept TALADEGIB Festuca Rubra Pollen Immunoglobulins, Normal Human More therapies…

    Learn about Your Condition

    Eosinophilic gastritis Meningioma malignant Optic atrophy Tendon rupture Haemorrhagic stroke Craniotomy Alveolar proteinosis Chronic disease Appendicitis perforated Angiosarcoma non-metastatic Craniopharyngioma Colorectal cancer stage IV Glomerulonephritis Osteoporosis postmenopausal Paedophilia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study of venetoclax, obinutuzumab and zanubrutinib combination therapy in young patients with high-risk Chronic Lymphocytic Leukemia and residual disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Allopurinol
    • Chlorphenamine Maleate
    • Lamivudine
    Italy

  • Study on the Safety and Effects of NXT007 for Patients with Severe or Moderate Hemophilia A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Factor VIII deficiency
    Investigated Drugs:
    • Ro7589655
    Italy Poland Spain

  • Study on Trametinib, Dexamethasone, Cyclophosphamide, and Cytarabine for Children with Relapsed or Refractory Blood Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Trametinib
    Austria Belgium Denmark Finland France Germany +5

  • Study on Radiotherapy Alone or with Obinutuzumab for Patients with Early Stage Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Obinutuzumab
    Italy

  • Study on Zanubrutinib and Rituximab for Patients with IgM Monoclonal Gammopathy and MAG Antibodies-Related Polyneuropathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Anti-myelin-associated glycoprotein associated polyneuropathy
    Investigated Drugs:
    • Zanubrutinib
    The Netherlands

  • Study on Conditioning Treatments with Busulfan, Clofarabine, and Fludarabine for Children with Acute Myeloid Leukemia Undergoing Stem Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Antithymocyte Immunoglobulin
    • Clofarabine
    • Anti-T Lymphocyte Immunoglobulin For Human Use, Rabbit
    Belgium Denmark Finland Lithuania The Netherlands Norway +1
Previous Page
1 … 27 28 29 30 31 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!